Roche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for Enhertu Ruchika Sharma12 April 2024 12:54 PM ISTTucson: Roche has announced the approval of the CE Mark for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx to identify...
Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients: JAMA Dr. Kamal Kant Kohli8 April 2024 6:45 AM ISTResearchers at The University of Texas MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation...
AstraZeneca, Daiichi Sankyo Datopotamab deruxtecan application accepted in US for pretreated metastatic HR-positive, HER2-negative breast cancer Ruchika Sharma3 April 2024 12:30 PM ISTAstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the...
Alembic Pharma gets tentative USFDA nod for breast cancer drug Ribociclib in March Quarter Ruchika Sharma2 April 2024 3:17 PM ISTVadodara: Alembic Pharma has informed in a BSE filing that the Company has received tentative approval for Ribociclib Tablets, 200 mg,...
AstraZeneca Truqap plus Faslodex gets nod in Japan for advanced HR-positive breast cancer Ruchika Sharma31 March 2024 2:30 PM ISTCambridge: AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment of adult...
AstraZeneca India bags dual CDSCO nod for Trastuzumab deruxtecan Ruchika Sharma28 March 2024 1:30 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized...
Medical AI tool uncovers breast cancer signs in 11 women that doctors overlooked Roshni Dhar27 March 2024 5:44 PM ISTIn a groundbreaking advancement for cancer detection, a medical AI tool named Mia has emerged as a potential game-changer in the fight against breast...
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence: NEJM Dr. Kamal Kant Kohli26 March 2024 11:15 PM ISTA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2...
Health Bulletin 26/ March/ 2024 Roshni Dhar26 March 2024 4:55 PM ISTHere are the top health news for the day:A Microsoft-powered medical AI spotted cancer in 11 women where doctors didn'tIn a groundbreaking advancement...
Combined PET-MRI scan could improve treatment for patients with early breast cancer: Study Dr. Kamal Kant Kohli24 March 2024 8:00 PM ISTUsing a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial...
Mammography-based AI model can predict 5-year breast cancer risk: Study Medha Baranwal21 March 2024 11:30 PM ISTUSA: Duke University researchers have developed an artificial intelligence (AI) model that can predict five-year breast cancer risk from mammograms,...
Annual mammography with clinical exam is "likely sufficient" than semiannual after breast-conserving surgery: Study Medha Baranwal20 March 2024 8:00 PM ISTUSA: A recent study found that evidence is insufficient to support semi-annual mammography in the early postoperative period after breast-conserving...
